Medical News

RSS

EPFL sets up foundation to release antibiotic for tuberculosis

Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.

12 Mar 2014

N30 Pharma begins oral dosing in N91115 Phase 1 trial for treatment of cystic fibrosis

N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).

12 Mar 2014

Precision and Agrivida enter into trait development collaboration based on precise gene modifications

Precision BioSciences and Agrivida revealed today that they have entered into a trait development collaboration based on precise gene modifications made possible by Precision's Directed Nuclease Editor (DNE) Technology.

12 Mar 2014

Parasites in human are most likely to interact via food source

Over 1,400 species of parasites - viruses, bacteria, fungi, intestinal worms and protozoa - are able to infect humans. In most cases, the right medicine against a parasite cures the patient.

12 Mar 2014

Bone healing cells in non-smokers are of better quality than those of smokers

Bone healing cells in non-smokers are of a better quality, more active and quicker at dividing than those of smokers, according to new research.

12 Mar 2014

Natural low-sodium salt ingredient addresses challenges to reduce sodium in bakery products, cereals

Salt of the Earth Ltd. introduces a novel, low-sodium sea salt ingredient to address food manufacturers' challenges to reduce sodium in bakery products, such as bread, breakfast cereals and snacks.

12 Mar 2014

Novalon Games signs LOI to license new biofeedback technology for mobile gaming applications

Novalon Games, a wholly owned subsidiary of OBJ Enterprises, announced today that it has signed a letter of intent (LOI) to partner with a cutting-edge game developer and potentially license innovative biofeedback technology for use in its growing suite of mobile gaming applications.

12 Mar 2014

Study questions conventional wisdom that patients should wait 6 weeks after hip replacement before driving

After hip replacement surgery, many patients are anxious to resume driving, and a new study challenges the conventional wisdom that patients should wait six weeks before getting back behind the wheel.

12 Mar 2014

STC Life and 97.7 B&H Clinic successfully treat pulmonary fibrosis patient

Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully finished mesenchymal stem cell therapy for the pulmonary fibrosis patient who visited Korea from Calgary, Canada.

12 Mar 2014

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Quintiles last night was named the "Best CRO in Asia" at the 2014 BioPharma Asia Industry Awards dinner, the third time in the event's four-year history that Quintiles has received the honor.

12 Mar 2014

GE announces winners of the GE Healthcare 2013 Cell Imaging Competition

GE Healthcare Life Sciences (NYSE:GE) today announced Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore as the winners of the GE Healthcare 2013 Cell Imaging Competition.

12 Mar 2014

Orexo signs multi-year agreement with OptumRx and UnitedHealth Group

Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.

12 Mar 2014

MUSC, Alliance Oncology announce strategic radiation therapy affiliation

The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.

12 Mar 2014

Suniva's Buy America-compliant modules power VA Medical Center

Suniva, Inc., a metro-Atlanta based manufacturer of high-quality, high-efficiency crystalline silicon solar cells and modules, today announces its Buy America-compliant modules power the Department of Veterans Affairs Medical Center (VAMC) in West Palm Beach, Florida.

12 Mar 2014

Health groups urge Governor and Legislature to raise Ohio’s tobacco tax

As organizations committed to reducing tobacco use, the number one cause of preventable death in Ohio, we welcome Gov. John Kasich's concern about this important public health issue.

12 Mar 2014

MEDIAN Technologies inks €700K deal with leading pharmaceutical company

MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, today announced it has signed a contract with a global top five pharmaceutical company.

12 Mar 2014

Nestlé, Biogaia sign new supplementary agreement

In February 2012 BioGaia sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle for the remainder of the patent lifetime

12 Mar 2014

CPhI to conduct the 4th NEXTGEN China 2014 Conference from March 27 to 28

In March 2012, the 1st Nextgen China was held successfully in Shanghai. FDA, USP, national institutes for Food and Drug Control and leading pharmaceutical companies from home and abroad were invited to give presentations.

12 Mar 2014

FDA clears Toshiba’s CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems.

12 Mar 2014

Washington Trust offers $8.8M to two medical centers located in Providence, RI

Washington Trust's Commercial Real Estate Group recently provided $8.8 million in financing for the refinancing of University Medical Center, LLC located at 195 Collyer St. in Providence, R.I. and Collyer Rehabilitation Center, LLC located at 208 Collyer St.

12 Mar 2014